This course has expired. View available courses.
Neurology
Initiating Treatment for MS: An Escalation Approach Versus Starting Early Intensive Treatment
Two different treatment paradigms are most often used in multiple sclerosis (MS): an “escalation approach” versus “early intensive treatment”. This program will discuss the difference between the two treatment paradigms and the rationale behind each approach. The goal is to provide clinicians with useful information that is relevant to their clinical practice when deciding how to treat their patients with MS.
This program has received an unrestricted educational grant or in-kind support from Roche.
DURATION
30 min
PROFESSION
Physician, Nursing, Pharmacy, Medical Resident, Specialist
# OF CREDITS
0.5
ACCREDITATION
MOC - Section 1, SCFHS
EXPIRY DATE
2023-03-09
Two different treatment paradigms are most often used in multiple sclerosis (MS): an “escalation approach” versus “early intensive treatment”. This program will discuss the difference between the two treatment paradigms and the rationale behind each approach. The goal is to provide clinicians with useful information that is relevant to their clinical practice when deciding how to treat their patients with MS.
This program has received an unrestricted educational grant or in-kind support from Roche.
Faculty
Yaser Al Malik, MD,FRCPC, American Board of Psychiatry and Neurology, CSCN (EEG & EMG)
Hani Aggad, MD
Learning objectives
Upon viewing the educational video and completing requirements, participants will be better able to:
- Differentiate between two MS treatment paradigms: an escalation strategy versus starting early intensive treatment.
- Review the clinical data and rationale behind each approach to MS management.
Accreditation
This Expert Brief Video is part of a multi-component learning series.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series
#
of credits: 0.5
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Physician, Nursing, Pharmacy, Medical Resident, Specialist
Profession
0.5
# of credits
Learning Objectives
Upon viewing the educational video and completing requirements, participants will be better able to:
- Differentiate between two MS treatment paradigms: an escalation strategy versus starting early intensive treatment.
- Review the clinical data and rationale behind each approach to MS management.
MOC - Section 1, SCFHS
ACCREDITATION
Neurology
Learning Category
Medication
Topic
0
Price
2023-03-09
Expiry Date
CAN-eng, MENA
Region/Language
Course Description
Two different treatment paradigms are most often used in multiple sclerosis (MS): an “escalation approach” versus “early intensive treatment”. This program will discuss the difference between the two treatment paradigms and the rationale behind each approach. The goal is to provide clinicians with useful information that is relevant to their clinical practice when deciding how to treat their patients with MS.
This program has received an unrestricted educational grant or in-kind support from Roche.
Faculty
Yaser Al Malik, MD,FRCPC, American Board of Psychiatry and Neurology, CSCN (EEG & EMG)
Hani Aggad, MD
Accreditation
This Expert Brief Video is part of a multi-component learning series.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series
30 min
Duration
0
Price
0.5
# of credits
